Grant: CIHR Fellowship
Direct Payment
$112,500.00
Investigating the role of serotonin on hematopoietic stem cell development, maintenance, and differentiation
EF 2013-14
Résumé
Blood stem cells, or hematopoietic stem cells (HSCs), form the entire blood system. Disruption of the normal programs in HSCs can lead to various blood disorders like leukemia. The process of how HSCs develop and function pertain to the mechanisms whereby these signals are affected in disease. Because the genetic programs regulating the blood system are highly conserved, our lab uses zebrafish as a model to study HSC production and function. Changes in zebrafish blood regulation could directly reflect influence on human conditions. We recently identified novel modulators of HSC production. Prostaglandin E2 (PGE2) was identified as an important HSCs regulator, which led to a FDA-approved clinical trial investigating PGE2 effect on human cord blood stem cell expansion for HSC transplantation (HSCT) therapies. Of other modulators identified, serotonin also altered HSC development. Serotonin is found both in the brain and in the body. In the brain, serotonin is released by specific nerve cells and then triggers other brain regions to induce a response. Serotonin can also be released in the body and have direct effects in those organs. Here, we propose that serotonin affects HSC development via changing serotonin-induced signals in the brain and/or directly at the site of HSC formation. These signals may also initiate or propagate blood cancers. We will first dissect the effect and mechanism of serotonin in the brain and body on HSC development, maintenance, and formation of mature immune cells. Secondly, we will investigate the effects of serotonin on the ability of HSCs to recover after injury and produce each of the mature blood lineages. We will further apply this knowledge to uncover how serotonin and its downstream signals may alter leukemia biology. Taken together, this study will unveil novel targets on HSC development and function, and will have biomedical applications towards the treatment of hematopoietic malignancies and/or recovery after HSCT therapies.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
300767
Name
Kwan Wanda
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Investigating the role of serotonin on hematopoietic stem cell development, maintenance, and differentiation
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$112,500
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Development; Flow Cytometry; Hematology; Hematopoietic Stem Cells; In Situ Hybridization; Leukemia; Molecular Biology; Neurology; Zebrafish
Abstract
Blood stem cells, or hematopoietic stem cells (HSCs), form the entire blood system. Disruption of the normal programs in HSCs can lead to various blood disorders like leukemia. The process of how HSCs develop and function pertain to the mechanisms whereby these signals are affected in disease. Because the genetic programs regulating the blood system are highly conserved, our lab uses zebrafish as a model to study HSC production and function. Changes in zebrafish blood regulation could directly reflect influence on human conditions. We recently identified novel modulators of HSC production. Prostaglandin E2 (PGE2) was identified as an important HSCs regulator, which led to a FDA-approved clinical trial investigating PGE2 effect on human cord blood stem cell expansion for HSC transplantation (HSCT) therapies. Of other modulators identified, serotonin also altered HSC development. Serotonin is found both in the brain and in the body. In the brain, serotonin is released by specific nerve cells and then triggers other brain regions to induce a response. Serotonin can also be released in the body and have direct effects in those organs. Here, we propose that serotonin affects HSC development via changing serotonin-induced signals in the brain and/or directly at the site of HSC formation. These signals may also initiate or propagate blood cancers. We will first dissect the effect and mechanism of serotonin in the brain and body on HSC development, maintenance, and formation of mature immune cells. Secondly, we will investigate the effects of serotonin on the ability of HSCs to recover after injury and produce each of the mature blood lineages. We will further apply this knowledge to uncover how serotonin and its downstream signals may alter leukemia biology. Taken together, this study will unveil novel targets on HSC development and function, and will have biomedical applications towards the treatment of hematopoietic malignancies and/or recovery after HSCT therapies.
Competitiondate
201311
Approvedterm2
2 yrs 3 mths
Pinamesdelim
Kwan, Wanda
Approvedterm
2 ans 3 mois
Cihrcontribution2
~ $112,500~ $0~